Filing Details
- Accession Number:
- 0001209191-22-031634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-24 16:47:38
- Reporting Period:
- 2022-05-23
- Accepted Time:
- 2022-05-24 16:47:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1903088 | Setareh Seyedkazemi | C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-23 | 20,000 | $0.84 | 20,600 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
